EP2820013
Lifrar X viðtaka (LXR) stillar til meðhöndlunar á húðsjúkdómum, húðkvillum og húðástöndum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.2.2013EP published:
11.7.2018EP application number:
13754329.4
EP translation filed:
16.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
27.2.2033Expiry date:
27.2.2022
Title:
LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS
Timeline
Today
28.2.2013EP application
11.7.2018EP Publication
16.10.2018Translation submitted
15.11.2018Registration published
27.2.2022Expires
Owner
Name:
Ralexar Therapeutics, Inc.Address:
101 Lindenwood Drive, Suite 400, 19355, Malvern, PA, US
Inventor
Name:
MOHAN, RajuAddress:
EncinitasCalifornia, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261606160 PDate:
2.3.2012Country:
US
Classification
Categories:
C07D 417/04, C07D 413/04, A61K 31/4155, A61K 31/433, A61K 31/4245, A61P 17/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 19.3.2019
Expires: 27.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.4.2020
Expires: 27.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 15.8.2021
Expires: 27.2.2022
Payer: Sigurjónsson & Thor ehf.